PARK HA BIOLOGICAL TECHNOLOGY Stock Price, News & Analysis
Company Description
Park Ha Biological Technology Co., Ltd. (Nasdaq: BYAH) is a company whose business activities, according to available information, center on skincare and cosmetic products marketed under the Park Ha brand in China. The company is involved in developing its own private skincare label and distributing these products through direct sales and franchise-related promotion channels. Its brand positioning focuses on providing solutions for problematic skin, and its operating subsidiaries handle both product development and customer-facing services in physical locations.
Business focus and activities
Park Ha Biological Technology Co., Ltd. is engaged in the development of proprietary beauty and skincare products under the Park Ha name. Based on the available description, the company’s operating subsidiaries provide skincare and cosmetic products under this brand in China and are responsible for creating and refining the company’s own beauty formulations.
The company also conducts direct skincare product sales and participates in franchise alliances promotions. This indicates that, in addition to selling products directly, it works with franchise partners to promote its brand and offerings. Its physical stores provide complimentary after-sales beauty services, which are positioned as a way to support customers who use Park Ha products and to reinforce the brand’s focus on problematic skin.
Brand positioning
The Park Ha brand is described as focusing on solutions for problematic skin. Within this framework, the company emphasizes proprietary beauty products and after-sales beauty services offered in physical stores. These services are characterized as complimentary and are intended to support customers following their purchase of Park Ha skincare or cosmetic products.
Trading symbol and Nasdaq listing
Park Ha Biological Technology Co., Ltd. has announced that its ordinary shares trade on Nasdaq. The company stated that it would change its ticker symbol from PHH to BYAH, and that, effective on October 28, 2025, its ordinary shares would trade on Nasdaq under the new symbol BYAH. The company has indicated that its ordinary shares will continue to be listed on Nasdaq in connection with this symbol change and that the CUSIP will remain unchanged.
According to the company’s announcement, the purpose of the ticker symbol change is to prevent potential confusion with a previously delisted company that used the same symbol. The company also stated that it expects the change of ticker symbol to support the development of its long-term brand influence and brand value.
Corporate structure and operations
Available information notes that Park Ha Biological Technology Co., Ltd. operates through its operating subsidiaries, which develop proprietary beauty products and offer complimentary after-sales beauty services in physical stores. These subsidiaries are responsible for providing skincare and cosmetic products under the Park Ha brand in China.
The company’s activities, as described, combine product development, brand-focused marketing, and in-person services. Direct skincare product sales and franchise alliances promotions are mentioned as key channels through which the Park Ha brand is promoted and its products are brought to customers.
Investor considerations
From an investor information standpoint, Park Ha Biological Technology Co., Ltd. presents itself as a skincare and cosmetic products company with a specific focus on problematic skin and a brand-based strategy in China. Its Nasdaq listing under the symbol BYAH and the formal announcement of its ticker symbol change from PHH to BYAH are key structural details disclosed by the company.
Investors reviewing Park Ha Biological Technology Co., Ltd. can consider the company’s emphasis on proprietary product development, its use of physical stores to provide complimentary after-sales beauty services, and its reliance on both direct sales and franchise alliances promotions as described in available materials. The company has also publicly communicated that the ticker symbol change is intended to avoid confusion with a delisted company that previously used the same symbol and to support its brand-building efforts.
Stock Performance
PARK HA BIOLOGICAL TECHNOLOGY (BYAH) stock last traded at $1.07, up 0.90% from the previous close. Over the past 12 months, the stock has lost 94.3%. At a market capitalization of $3.5M, BYAH is classified as a micro-cap stock with approximately 3.2M shares outstanding.
BYAH Rankings
Latest News
PARK HA BIOLOGICAL TECHNOLOGY has 3 recent news articles. Of the recent coverage, 0 articles coincided with positive price movement and 2 with negative movement. Key topics include offering. View all BYAH news →
SEC Filings
PARK HA BIOLOGICAL TECHNOLOGY has filed 5 recent SEC filings, including 4 Form 3, 1 Form F-3. The most recent filing was submitted on April 16, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BYAH SEC filings →
Financial Highlights
PARK HA BIOLOGICAL TECHNOLOGY generated $2.5M in revenue over the trailing twelve months, retaining a 94.4% gross margin, operating income reached -$24.1M (-956.5% operating margin), and net income was -$24.4M, reflecting a -965.0% net profit margin. Diluted earnings per share stood at $-41.38. The company generated $86K in operating cash flow. With a current ratio of 2.92, the balance sheet reflects a strong liquidity position.
Upcoming Events
Short Interest History
Short interest in PARK HA BIOLOGICAL TECHNOLOGY (BYAH) currently stands at 40.6 thousand shares, down 42.2% from the previous reporting period, representing 1.5% of the float. Over the past 12 months, short interest has decreased by 64.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for PARK HA BIOLOGICAL TECHNOLOGY (BYAH) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 2.0 days.
BYAH Company Profile & Sector Positioning
PARK HA BIOLOGICAL TECHNOLOGY (BYAH) operates in the Household & Personal Products industry within the broader Consumer Defensive sector and is listed on the NASDAQ.